Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $24.07 USD
Change Today -0.15 / -0.62%
Volume 1.5M
EXAS On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

EXAS

Industry Average

Ratio data TTM as of 06/30/2015

Profitability - exact sciences corp (EXAS)

Return on Assets

Industry Comparison
-34.43%

Return on Equity

Industry Comparison
-59.60%

Return on Capital

Industry Comparison
-37.06%

Margin Analysis - exact sciences corp (EXAS)

Gross Margin

Industry Comparison
1.86%

Levered Free Cash Flow Margin

Industry Comparison
--
No data available

EBITDA Margin

Industry Comparison
-969.32%

SG&A Margin

Industry Comparison
804.06%

Asset Turnover - exact sciences corp (EXAS)

Total Assets Turnover

Industry Comparison
0.1x

Accounts Receivables Turnover

Industry Comparison
--
No data available

Fixed Assets Turnover

Industry Comparison
0.6x

Inventory Turnover

Industry Comparison
--
No data available

Credit Ratios - exact sciences corp (EXAS)

Current Ratio

Industry Comparison
11.9x

Quick Ratio

Industry Comparison
11.4x

Long-Term Solvency - exact sciences corp (EXAS)

Total Debt/Equity

Industry Comparison
1.55%

Total Liabilities/Total Assets

Industry Comparison
11.14%

Growth Over Prior Year - exact sciences corp (EXAS)

Total Revenue

Industry Comparison
487.02%

Tangible Book Value

Industry Comparison
-7.42%

EBITDA

Industry Comparison
135.59%

Gross Profit

Industry Comparison
-89.10%

Receivables

Industry Comparison
--
No data available

Inventory

Industry Comparison
--
No data available

Diluted EPS Before Extra

Industry Comparison
101.80%

Capital Expenditures

Industry Comparison
--
No data available

Cash From Ops.

Industry Comparison
--
No data available

Levered Free Cash Flow

Industry Comparison
--
No data available
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EXAS:US $24.07 USD -0.15

EXAS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Celldex Therapeutics Inc $23.55 USD +0.03
Curis Inc $3.14 USD -0.06
Navidea Biopharmaceuticals Inc $1.72 USD +0.02
Veracyte Inc $11.60 USD +0.47
ZIOPHARM Oncology Inc $13.36 USD +0.46
View Industry Companies
 

Industry Analysis

EXAS

Industry Average

Valuation EXAS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 154.1x
Price/Book 9.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 150.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EXACT SCIENCES CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.